Surgical management of stone disease in patients with primary hyperoxaluria

Alonso Carrasco, Candace F. Granberg, Matthew T. Gettman, Dawn S. Milliner, Amy Krambeck

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective To present our experience with surgical management of nephrolithiasis in patients with primary hyperoxaluria (PH). Methods A retrospective chart review from 1994 to 2012 was performed to identify patients with diagnosis of PH. Results A total of 14 patients with PH were identified with a median follow-up of 18.6 years (range, 0.9-51 years). Median ages at initial symptom and subsequent diagnosis were 6.7 years (range, 1.1-35.5 years) and 0.42 years (range, 0-33.25 years), respectively. Patients underwent a total of 54 procedures at our institution, including ureteroscopy (27 [50%]), percutaneous nephrolithotomy (15 [28%]), shock wave lithotripsy (8 [15%]), and combined procedures (4 [7%]). Overall nonintraparenchymal stone-free rate after the first, second, and third procedures were 59%, 76%, and 78%, respectively. On average, 1.6 procedures (range, 1-4) were required to rid patients of symptomatic stones, which subsequently afforded them a mean of 3.62 years (range, 0.25-21.5 years) without the need for additional intervention. There were 6 Clavien grade ≥III complications in 4 patients, including immediate postoperative end-stage renal disease in 3 patients. Conclusion Despite optimal medical and surgical management, patients experience recurrent acute stone events requiring multiple urologic interventions. Significant complications such as end-stage renal disease can occur secondary to surgical intervention.

Original languageEnglish (US)
Pages (from-to)522-526
Number of pages5
JournalUrology
Volume85
Issue number3
DOIs
StatePublished - Mar 1 2015
Externally publishedYes

Fingerprint

Primary Hyperoxaluria
Disease Management
Chronic Kidney Failure
Ureteroscopy
Percutaneous Nephrostomy
Nephrolithiasis
Lithotripsy

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Surgical management of stone disease in patients with primary hyperoxaluria. / Carrasco, Alonso; Granberg, Candace F.; Gettman, Matthew T.; Milliner, Dawn S.; Krambeck, Amy.

In: Urology, Vol. 85, No. 3, 01.03.2015, p. 522-526.

Research output: Contribution to journalArticle

Carrasco, A, Granberg, CF, Gettman, MT, Milliner, DS & Krambeck, A 2015, 'Surgical management of stone disease in patients with primary hyperoxaluria', Urology, vol. 85, no. 3, pp. 522-526. https://doi.org/10.1016/j.urology.2014.11.018
Carrasco, Alonso ; Granberg, Candace F. ; Gettman, Matthew T. ; Milliner, Dawn S. ; Krambeck, Amy. / Surgical management of stone disease in patients with primary hyperoxaluria. In: Urology. 2015 ; Vol. 85, No. 3. pp. 522-526.
@article{5a91862654fa4cd59105f8d0a45f860b,
title = "Surgical management of stone disease in patients with primary hyperoxaluria",
abstract = "Objective To present our experience with surgical management of nephrolithiasis in patients with primary hyperoxaluria (PH). Methods A retrospective chart review from 1994 to 2012 was performed to identify patients with diagnosis of PH. Results A total of 14 patients with PH were identified with a median follow-up of 18.6 years (range, 0.9-51 years). Median ages at initial symptom and subsequent diagnosis were 6.7 years (range, 1.1-35.5 years) and 0.42 years (range, 0-33.25 years), respectively. Patients underwent a total of 54 procedures at our institution, including ureteroscopy (27 [50{\%}]), percutaneous nephrolithotomy (15 [28{\%}]), shock wave lithotripsy (8 [15{\%}]), and combined procedures (4 [7{\%}]). Overall nonintraparenchymal stone-free rate after the first, second, and third procedures were 59{\%}, 76{\%}, and 78{\%}, respectively. On average, 1.6 procedures (range, 1-4) were required to rid patients of symptomatic stones, which subsequently afforded them a mean of 3.62 years (range, 0.25-21.5 years) without the need for additional intervention. There were 6 Clavien grade ≥III complications in 4 patients, including immediate postoperative end-stage renal disease in 3 patients. Conclusion Despite optimal medical and surgical management, patients experience recurrent acute stone events requiring multiple urologic interventions. Significant complications such as end-stage renal disease can occur secondary to surgical intervention.",
author = "Alonso Carrasco and Granberg, {Candace F.} and Gettman, {Matthew T.} and Milliner, {Dawn S.} and Amy Krambeck",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.urology.2014.11.018",
language = "English (US)",
volume = "85",
pages = "522--526",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Surgical management of stone disease in patients with primary hyperoxaluria

AU - Carrasco, Alonso

AU - Granberg, Candace F.

AU - Gettman, Matthew T.

AU - Milliner, Dawn S.

AU - Krambeck, Amy

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Objective To present our experience with surgical management of nephrolithiasis in patients with primary hyperoxaluria (PH). Methods A retrospective chart review from 1994 to 2012 was performed to identify patients with diagnosis of PH. Results A total of 14 patients with PH were identified with a median follow-up of 18.6 years (range, 0.9-51 years). Median ages at initial symptom and subsequent diagnosis were 6.7 years (range, 1.1-35.5 years) and 0.42 years (range, 0-33.25 years), respectively. Patients underwent a total of 54 procedures at our institution, including ureteroscopy (27 [50%]), percutaneous nephrolithotomy (15 [28%]), shock wave lithotripsy (8 [15%]), and combined procedures (4 [7%]). Overall nonintraparenchymal stone-free rate after the first, second, and third procedures were 59%, 76%, and 78%, respectively. On average, 1.6 procedures (range, 1-4) were required to rid patients of symptomatic stones, which subsequently afforded them a mean of 3.62 years (range, 0.25-21.5 years) without the need for additional intervention. There were 6 Clavien grade ≥III complications in 4 patients, including immediate postoperative end-stage renal disease in 3 patients. Conclusion Despite optimal medical and surgical management, patients experience recurrent acute stone events requiring multiple urologic interventions. Significant complications such as end-stage renal disease can occur secondary to surgical intervention.

AB - Objective To present our experience with surgical management of nephrolithiasis in patients with primary hyperoxaluria (PH). Methods A retrospective chart review from 1994 to 2012 was performed to identify patients with diagnosis of PH. Results A total of 14 patients with PH were identified with a median follow-up of 18.6 years (range, 0.9-51 years). Median ages at initial symptom and subsequent diagnosis were 6.7 years (range, 1.1-35.5 years) and 0.42 years (range, 0-33.25 years), respectively. Patients underwent a total of 54 procedures at our institution, including ureteroscopy (27 [50%]), percutaneous nephrolithotomy (15 [28%]), shock wave lithotripsy (8 [15%]), and combined procedures (4 [7%]). Overall nonintraparenchymal stone-free rate after the first, second, and third procedures were 59%, 76%, and 78%, respectively. On average, 1.6 procedures (range, 1-4) were required to rid patients of symptomatic stones, which subsequently afforded them a mean of 3.62 years (range, 0.25-21.5 years) without the need for additional intervention. There were 6 Clavien grade ≥III complications in 4 patients, including immediate postoperative end-stage renal disease in 3 patients. Conclusion Despite optimal medical and surgical management, patients experience recurrent acute stone events requiring multiple urologic interventions. Significant complications such as end-stage renal disease can occur secondary to surgical intervention.

UR - http://www.scopus.com/inward/record.url?scp=84961344778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961344778&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2014.11.018

DO - 10.1016/j.urology.2014.11.018

M3 - Article

C2 - 25733260

AN - SCOPUS:84961344778

VL - 85

SP - 522

EP - 526

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -